XML 165 R118.htm IDEA: XBRL DOCUMENT v3.24.1
Schedule II - Condensed Financial Information of Registrant Statements of Cash Flows (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Amortization of right-of-use operating lease assets $ 10,700,000 $ 10,100,000 $ 12,000,000.0
Interest on operating lease liability (4,500,000) (5,400,000) (5,500,000)
Change in right of lease assets 0 (6,700,000) 400,000
Change in operating lease liabilities (15,500,000) (15,500,000) (17,500,000)
Net cash provided by/(used in) operating activities 324,700,000 (55,000,000.0) 524,700,000
Cash flows from investing activities:      
Proceeds from sales and maturities of fixed income securities — Trading 474,000,000.0 293,600,000 548,200,000
Net cash (used in) investing activities (172,200,000) (196,500,000) (950,300,000)
Cash flows from financing activities:      
Repayments of Short-Term Debt (300,000,000.0) 0 0
Proceeds from term loan facility 300,000,000.0 0 0
Payments of Ordinary Dividends, Common Stock (40,300,000) (40,000,000.0) 0
Payments of Ordinary Dividends, Preferred Stock and Preference Stock 49,900,000 44,600,000 44,500,000
Net cash (used in)/provided by financing activities (90,200,000) (84,600,000) 500,000
(Decrease) in cash and cash equivalents 68,900,000 (354,900,000) (433,200,000)
Cash and cash equivalents at beginning of period [1] 959,200,000    
Cash and cash equivalents at end of period (1) [1] 1,028,100,000 959,200,000  
Parent      
Cash flows from financing activities:      
Proceeds from term loan facility 300,000,000.0 0 0
Parent Company      
Cash flows from operating activities:      
Net income (excluding equity in net earnings of subsidiaries) 230,000,000.0 36,900,000 120,300,000
Realized and unrealized (gains)/losses (14,800,000) 19,700,000 (6,700,000)
Loss/(gain) on derivative contracts 14,000,000.0 (15,400,000) 6,200,000
Amortization of right-of-use operating lease assets 500,000 500,000 500,000
Interest on operating lease liability 100,000 100,000 100,000
Change in other assets 300,000 2,100,000 (1,600,000)
Change in accrued expenses and other payables 5,500,000 (3,200,000) 1,400,000
Change in intercompany activities (38,400,000) 41,100,000 35,000,000.0
Change in right of lease assets 0 0 (2,000,000.0)
Change in operating lease liabilities (500,000) (600,000) 1,500,000
Net cash provided by/(used in) operating activities 196,700,000 81,200,000 154,700,000
Cash flows from investing activities:      
(Purchases) of fixed income securities (8,100,000) (10,000,000.0) (42,600,000)
Proceeds from sales and maturities of fixed income securities — Trading 6,400,000 7,800,000 0
Investment in subsidiaries (105,700,000) 5,000,000.0 (115,000,000.0)
Net cash (used in) investing activities (107,400,000) 2,800,000 (157,600,000)
Cash flows from financing activities:      
Repayments of Short-Term Debt (300,000,000.0) 0 0
Net cash (used in)/provided by financing activities (90,200,000) (84,600,000) (44,500,000)
(Decrease) in cash and cash equivalents (900,000) (600,000) (47,400,000)
Cash and cash equivalents at beginning of period 44,400,000 45,000,000.0 92,400,000
Cash and cash equivalents at end of period (1) $ 43,500,000 $ 44,400,000 $ 45,000,000.0
[1] Cash and cash equivalents includes restricted cash of $323.2 million (2022 — $232.1 million) which are held in trusts.